Mock-up Updates Study Tags (field_study_tags) - Any - ADEQUATE BE READY NOW Blog Call-outs CLIN-Net CoMeCT COVID-19 Data Ecraid ECRAID-Base Education EPI-Net EPOXI Interview Mpox NeoDeco NOFLU Partners People PIPELINE POS-ARI-ER POS-ARI-PC POS-cUTI POS-Disease X POS-VAP Primary Care PrIMAVeRA PRUDENCE RECLAIM RECOVERY REMAP-CAP SNAP SOS Covid STRIDE-CAP Training Vaccines 8.10.2026 Partner for Impact 2026 Connecting Scientific Expertise to Advance Infectious Disease and AMR Research 1.10.2026 Join the 3rd Ecraid Foundation Science Meeting 2027 Registration is now open! The next Ecraid Foundation Science Meeting takes place on 2 and 3 February in Verona, Italy. 29.09.2026 ECRAID-Prime shares findings at ESCV & ICTMC 2026 Consortium partners share ECRAID-Prime’s work with audiences in clinical virology and clinical trials methodology. 15.09.2026 Interview with Christian Lütken on his partnership with Ecraid 4.09.2026 Ecraid supports WHO Industry Dialogue on Global Antibiotic Development 19.08.2026 REMAP-CAP Finds Oseltamivir Ineffective in Critically Ill Influenza Patients Read the REMAP-CAP results from the recent preprint. Load More
8.10.2026 Partner for Impact 2026 Connecting Scientific Expertise to Advance Infectious Disease and AMR Research
1.10.2026 Join the 3rd Ecraid Foundation Science Meeting 2027 Registration is now open! The next Ecraid Foundation Science Meeting takes place on 2 and 3 February in Verona, Italy.
29.09.2026 ECRAID-Prime shares findings at ESCV & ICTMC 2026 Consortium partners share ECRAID-Prime’s work with audiences in clinical virology and clinical trials methodology.
19.08.2026 REMAP-CAP Finds Oseltamivir Ineffective in Critically Ill Influenza Patients Read the REMAP-CAP results from the recent preprint.
